ID

30655

Descrizione

Panitumumab DDI Irinotecan; ODM derived from: https://clinicaltrials.gov/show/NCT00563316

collegamento

https://clinicaltrials.gov/show/NCT00563316

Keywords

versioni (1)
  1. 19/06/18 19/06/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

19 giugno 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Metastatic Colorectal Cancer NCT00563316

Inglese

Eligibility Metastatic Colorectal Cancer NCT00563316

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
pathologically confirmed unresectable mcrc which has progressed on at least one prior 5-fluorouracil (5fu)-containing chemotherapy regimen
Descrizione

Colorectal cancer metastatic unresectable | Disease Progression | Chemotherapy Regimen Quantity | Fluorouracil

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0948380
UMLS CUI [1,2]
C1519810
UMLS CUI [2]
C0242656
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1265611
UMLS CUI [4]
C0016360
eastern cooperative oncology group (ecog) performance status of 0, 1, or 2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy of >/= 3 months as documented by the investigator
Descrizione

Life Expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
baseline actual body weight </=160 kg
Descrizione

Body Weight

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005910
competent to comprehend, sign, and date a written iec/irb approved informed consent form before any study-specific procedures are performed
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
treatment with radiotherapy </= 14 days before enrollment. patients must have recovered from all radiotherapy-related toxicities
Descrizione

Therapeutic radiology procedure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1522449
known presence of central nervous systems (cns) metastases
Descrizione

CNS metastases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0686377
any prior malignancy (except for non-melanomatous skin cancer or in situ cervical cancer) other than the study disease, unless treated with curative intent with no evidence of disease </= 2 years before enrollment
Descrizione

Cancer Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Disease Free of

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0012634
UMLS CUI [4,3]
C0332296
history of interstitial lung disease (eg, pneumonitis or pulmonary fibrosis) or evidence of interstitial lung disease on baseline chest ct scan
Descrizione

Lung Diseases, Interstitial | Pneumonitis | Pulmonary Fibrosis | Interstitial Lung Disease Chest CT

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0206062
UMLS CUI [2]
C3714636
UMLS CUI [3]
C0034069
UMLS CUI [4,1]
C0206062
UMLS CUI [4,2]
C0202823
active inflammatory bowel disease or other bowel disease causing chronic diarrhea (defined as > ctc grade 2 [ctcae version 3])
Descrizione

Inflammatory Bowel Diseases | Intestinal Diseases Causing Chronic diarrhea | Intestinal Diseases CTCAE Grades

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2,1]
C0021831
UMLS CUI [2,2]
C0678227
UMLS CUI [2,3]
C0401151
UMLS CUI [3,1]
C0021831
UMLS CUI [3,2]
C1516728
clinically significant cardiovascular disease (including myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) </= 1 year before enrollment
Descrizione

Cardiovascular Disease | Myocardial Infarction | Angina, Unstable | Symptomatic congestive heart failure | Cardiac Arrhythmia Serious Uncontrolled

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0027051
UMLS CUI [3]
C0002965
UMLS CUI [4]
C0742758
UMLS CUI [5,1]
C0003811
UMLS CUI [5,2]
C0205404
UMLS CUI [5,3]
C0205318
ugt1a1*28 ta7/7, ta7/8, ta8/8 genetic polymorphisms; gilbert's disease
Descrizione

UGT1A1*28 Allele Genetic Polymorphism | Gilbert Disease

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2825127
UMLS CUI [1,2]
C0032529
UMLS CUI [2]
C0017551
treatment with cyp3a4 enzyme inhibiting or inducing medications </= 2 weeks before enrollment
Descrizione

CYP3A4 Inhibitors | CYP3A4 Inducer

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3850053
UMLS CUI [2]
C3830625
prior anti-egfr antibody therapy (eg, cetuximab) or treatment with small molecule egfr inhibitors (eg, gefitinib, erlotinib, lapatinib)
Descrizione

Anti-egfr monoclonal antibody therapy | cetuximab | Small Molecule EGFR inhibitor | gefitinib | erlotinib | lapatinib

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4316122
UMLS CUI [2]
C0995188
UMLS CUI [3,1]
C1328819
UMLS CUI [3,2]
C1443775
UMLS CUI [4]
C1122962
UMLS CUI [5]
C1135135
UMLS CUI [6]
C1506770
systemic chemotherapy, hormonal therapy, immunotherapy, or experimental or approved proteins/antibodies (eg, bevacizumab) </= 30 days before enrollment
Descrizione

Systemic Chemotherapy | Hormone Therapy | Immunotherapy | Proteins Investigational | Antibodies Investigational | Proteins Approved | Antibodies Approved | Bevacizumab

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1883256
UMLS CUI [2]
C0279025
UMLS CUI [3]
C0021083
UMLS CUI [4,1]
C0033684
UMLS CUI [4,2]
C1517586
UMLS CUI [5,1]
C3495458
UMLS CUI [5,2]
C1517586
UMLS CUI [6,1]
C0033684
UMLS CUI [6,2]
C0205540
UMLS CUI [7,1]
C3495458
UMLS CUI [7,2]
C0205540
UMLS CUI [8]
C0796392
subjects requiring immunosuppressive agents (eg, methotrexate and cyclosporine), however corticosteroids are allowed
Descrizione

Immunosuppressive Agents | Methotrexate | Cyclosporine | Adrenal Cortex Hormones allowed

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021081
UMLS CUI [2]
C0025677
UMLS CUI [3]
C0010592
UMLS CUI [4,1]
C0001617
UMLS CUI [4,2]
C0683607
major surgery < 28 days prior to enrollment or minor surgery (excluding catheter placement) < 14 days before enrollment
Descrizione

Major surgery | Minor Surgical Procedures | Exception Catheter placement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C0038904
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0883301
Ritorna all'inizio della pagina

Similar models

Eligibility Metastatic Colorectal Cancer NCT00563316

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal cancer metastatic unresectable | Disease Progression | Chemotherapy Regimen Quantity | Fluorouracil
Item
pathologically confirmed unresectable mcrc which has progressed on at least one prior 5-fluorouracil (5fu)-containing chemotherapy regimen
boolean
C0948380 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C0242656 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0016360 (UMLS CUI [4])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of >/= 3 months as documented by the investigator
boolean
C0023671 (UMLS CUI [1])
Body Weight
Item
baseline actual body weight </=160 kg
boolean
C0005910 (UMLS CUI [1])
Informed Consent
Item
competent to comprehend, sign, and date a written iec/irb approved informed consent form before any study-specific procedures are performed
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure
Item
treatment with radiotherapy </= 14 days before enrollment. patients must have recovered from all radiotherapy-related toxicities
boolean
C1522449 (UMLS CUI [1])
CNS metastases
Item
known presence of central nervous systems (cns) metastases
boolean
C0686377 (UMLS CUI [1])
Cancer Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Disease Free of
Item
any prior malignancy (except for non-melanomatous skin cancer or in situ cervical cancer) other than the study disease, unless treated with curative intent with no evidence of disease </= 2 years before enrollment
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0012634 (UMLS CUI [4,2])
C0332296 (UMLS CUI [4,3])
Lung Diseases, Interstitial | Pneumonitis | Pulmonary Fibrosis | Interstitial Lung Disease Chest CT
Item
history of interstitial lung disease (eg, pneumonitis or pulmonary fibrosis) or evidence of interstitial lung disease on baseline chest ct scan
boolean
C0206062 (UMLS CUI [1])
C3714636 (UMLS CUI [2])
C0034069 (UMLS CUI [3])
C0206062 (UMLS CUI [4,1])
C0202823 (UMLS CUI [4,2])
Inflammatory Bowel Diseases | Intestinal Diseases Causing Chronic diarrhea | Intestinal Diseases CTCAE Grades
Item
active inflammatory bowel disease or other bowel disease causing chronic diarrhea (defined as > ctc grade 2 [ctcae version 3])
boolean
C0021390 (UMLS CUI [1])
C0021831 (UMLS CUI [2,1])
C0678227 (UMLS CUI [2,2])
C0401151 (UMLS CUI [2,3])
C0021831 (UMLS CUI [3,1])
C1516728 (UMLS CUI [3,2])
Cardiovascular Disease | Myocardial Infarction | Angina, Unstable | Symptomatic congestive heart failure | Cardiac Arrhythmia Serious Uncontrolled
Item
clinically significant cardiovascular disease (including myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) </= 1 year before enrollment
boolean
C0007222 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0002965 (UMLS CUI [3])
C0742758 (UMLS CUI [4])
C0003811 (UMLS CUI [5,1])
C0205404 (UMLS CUI [5,2])
C0205318 (UMLS CUI [5,3])
UGT1A1*28 Allele Genetic Polymorphism | Gilbert Disease
Item
ugt1a1*28 ta7/7, ta7/8, ta8/8 genetic polymorphisms; gilbert's disease
boolean
C2825127 (UMLS CUI [1,1])
C0032529 (UMLS CUI [1,2])
C0017551 (UMLS CUI [2])
CYP3A4 Inhibitors | CYP3A4 Inducer
Item
treatment with cyp3a4 enzyme inhibiting or inducing medications </= 2 weeks before enrollment
boolean
C3850053 (UMLS CUI [1])
C3830625 (UMLS CUI [2])
Anti-egfr monoclonal antibody therapy | cetuximab | Small Molecule EGFR inhibitor | gefitinib | erlotinib | lapatinib
Item
prior anti-egfr antibody therapy (eg, cetuximab) or treatment with small molecule egfr inhibitors (eg, gefitinib, erlotinib, lapatinib)
boolean
C4316122 (UMLS CUI [1])
C0995188 (UMLS CUI [2])
C1328819 (UMLS CUI [3,1])
C1443775 (UMLS CUI [3,2])
C1122962 (UMLS CUI [4])
C1135135 (UMLS CUI [5])
C1506770 (UMLS CUI [6])
Systemic Chemotherapy | Hormone Therapy | Immunotherapy | Proteins Investigational | Antibodies Investigational | Proteins Approved | Antibodies Approved | Bevacizumab
Item
systemic chemotherapy, hormonal therapy, immunotherapy, or experimental or approved proteins/antibodies (eg, bevacizumab) </= 30 days before enrollment
boolean
C1883256 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0033684 (UMLS CUI [4,1])
C1517586 (UMLS CUI [4,2])
C3495458 (UMLS CUI [5,1])
C1517586 (UMLS CUI [5,2])
C0033684 (UMLS CUI [6,1])
C0205540 (UMLS CUI [6,2])
C3495458 (UMLS CUI [7,1])
C0205540 (UMLS CUI [7,2])
C0796392 (UMLS CUI [8])
Immunosuppressive Agents | Methotrexate | Cyclosporine | Adrenal Cortex Hormones allowed
Item
subjects requiring immunosuppressive agents (eg, methotrexate and cyclosporine), however corticosteroids are allowed
boolean
C0021081 (UMLS CUI [1])
C0025677 (UMLS CUI [2])
C0010592 (UMLS CUI [3])
C0001617 (UMLS CUI [4,1])
C0683607 (UMLS CUI [4,2])
Major surgery | Minor Surgical Procedures | Exception Catheter placement
Item
major surgery < 28 days prior to enrollment or minor surgery (excluding catheter placement) < 14 days before enrollment
boolean
C0679637 (UMLS CUI [1])
C0038904 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0883301 (UMLS CUI [3,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial